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Abstract
Purpose: The aim of this study was to evaluate the possibility that migraine patients exhibit specific age-related meta-
bolic changes in the brain, which occur regardless of disease duration or the frequency of attacks.
Methods: We analysed the relation between brain glucose (18F-fluorodeoxyglucose) uptake and age in healthy volun-
teers (n¼ 20) and episodic migraine patients (n¼ 19). In the latter, we additionally compared the correlation between
18F-fluorodeoxyglucose uptake and disease duration and monthly migraine days.
Results: In contrast to controls, in migraine patients advancing age was positively correlated to increased metabolism
in the brainstem (especially the posterior pons), hippocampus, fusiform gyrus and parahippocampus. Conversely, no
significant correlations between cerebral metabolism and disease duration or migraine days were observed.
Conclusions: Findings of this cross-sectional study show that episodic migraine patients exhibit specific metabolic brain
modifications while ageing. As such, age is correlated with metabolic changes in key regions of the brain previously
associated with migraine’s pathophysiology to a better extent than disease duration or the number of monthly migraine
days. More than the repeated headache attacks, the continuous interaction with the environment seemingly models the
brain of migraine sufferers in an adaptive manner. A positive control (e.g. chronic pain) is missing in this study and
therefore findings cannot be proven to be migraine-specific.
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Introduction
One in every five women and one in every 15 men will
suffer from migraine at some point of their life (1).
Despite often being neglected, migraine entails a sub-
stantial disability at the personal level, and a tremen-
dous burden at the level of society (2,3). More than a
recurrent pain syndrome, migraine constitutes a brain
disease (4,5). A glance at migraine prevalence curves is
all it takes to realize that this condition is strongly
affected by the ageing process (6,7). Although hormo-
nal influences are non-neglectable, they are not suffi-
cient to explain the course of the disease in all
patients. Indeed, it is not uncommon for migraineurs
to have a history of painless clinical manifestations (e.g.
somnambulism, cyclic vomiting, vertigo) that occurred
early during childhood, years before puberty, and also
years before the diagnosis of migraine was actually
1Headache Research Unit, University Department of Neurology CHR,
Citadelle Hospital, University of Liège, Liège, Belgium
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established (8). Further in life, towards old age,
migraine tends to spontaneously remit, a phenomenon
perhaps less linked to the menopause than previously
thought (9).
Recently, in line with theoretical models (4), results
from an MRI study have suggested that the migraine
brain undergoes age-related structural modifications
regardless of the duration of the disease or the attack
frequency (10). This phenomenon has never been ana-
lysed from a metabolic perspective. The aim of the pre-
sent study was to evaluate the correlation between
cerebral glucose (18F-fluorodeoxyglucose) uptake and
age in healthy volunteers and migraine patients. In add-
ition, in order to separately evaluate the influence of
age, disease duration, and migraine days on brain
metabolism, we performed multivariate regressions




Forty-one subjects participated in this study: 20 healthy
volunteers and 21 episodic migraine patients (migraine
without aura patients diagnosed according to The
International Classification of Headache Disorders
3rd edition (beta version) of the International
Headache Society) (11) recruited by posting advertise-
ments on the University web page or via the headache
clinic. Except for migraine, subjects were devoid of any
neurologic or systemic disease. Healthy volunteers did
not report having any first-degree relative suffering
from recurrent headache of any type. Patients were
not under any migraine preventive treatment for at
least 30 days preceding imaging. Only the scans of
migraine patients performed during the interictal
period (at least 48 hours after their last headache epi-
sode, and at least 48 hours before the next one) were
included in the analyses. For this reason, scans from
two patients had to be excluded after headache diary
examination.
Compliance with ethical standards
Ethical approval was granted by the Institution’s ethics
committee (Centre Hospitalier Régional de la Citadelle,
Liège, Belgium – protocol n1422). The study was con-
ducted in accordance with the ethical standards of the
institutional research committee and with the 1964
Helsinki declaration and its later amendments or com-
parable ethical standards. Informed consent was
obtained from all individual participants included in
the study. This project forms part of the
EUROHEADPAIN project, FP7 n602633.
FDG-PET
PET acquisitions were made in the Nuclear Medicine
Department of the Centre Hospitalier Universitaire
(CHU) Sart Tilman, Liège, Belgium, using a Gemini
TF PET/computed tomography (CT) scanner (Philips,
Eindhoven, The Netherlands). Resting cerebral metab-
olism was studied 30 minutes after intravenous injec-
tion of 150MBq 18F-fluorodeoxyglucose (FDG). Blood
glucose level was lower than 110mg/dl in all partici-
pants. Subjects were injected and scanned in a dark
room with minimal environmental noise. Images were
reconstructed using an iterative list mode time-of-flight
algorithm. Corrections for attenuation, dead-time,
random and scatter events were applied.
Image analyses
PET scans were analysed using Statistical Parametric
Mapping version 12 (SPM12, Wellcome Trust Centre
for Neuroimaging, http://www.fil.ion.ucl.ac.uk/spm)
implemented in MATLAB 7.4.0 (MathWorks Inc,
Sherborn, MA, USA). Images were first manually
reoriented and then spatially normalised into a stand-
ard stereotactic space using an MNI PET template
(Montreal Neurological Institute) and smoothed using
an 8mm full-width-half-maximum isotropic kernel. We
performed global normalisation by applying propor-
tional scaling. In order to evaluate the brain metabolic
modifications associated with age, we identified voxels
in which age was correlated with resting 18FDG uptake.
Positive and negative correlations with age were
explored. We also separately performed voxel-wise
multiple regression analyses to test the effect of age,
disease duration, and migraine days on brain metabol-
ism, when acting as either variables of interest or nui-
sance variables. Finally, we performed t-tests
(one-sided t-tests for positive and negative contrasts)
to compare resting 18FDG uptake in migraine patients
and healthy controls with and without controlling for
age. Unless otherwise clarified, only regions surviving a
peak or cluster pFWE< 0.05 correction at a whole
brain level are reported in the results section. The stat-
istical significance threshold was set at p< 0.001
(uncorrected) for exploratory and display purposes.
No constraints regarding the minimum extent thresh-
old (number of voxels) for detecting clusters were
applied. Brain regions were identified using the
Neuromorphometrics atlas (Somerville, MA, USA)
implemented in SPM12.
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Results
Participants’ characteristics
Participants’ characteristics are summarized in Table 1.
No differences in age means (t¼ 0.415; p¼ 0.68), age
variances (F¼ 1.631; p¼ 0.30), or gender proportions
(2¼ 0.008; p¼ 0.93) were observed between migraine
patients and controls. The age range in both groups
extended over the migraine prevalence peak (Figure 1).
Age-metabolism correlations and correlations with
other clinical variables in migraine
In correlation with age, migraine patients exhibited sig-
nificantly augmented FDG uptake in the brainstem
(posterior pons) (4, 38, 38; T¼ 7.42; peak level
pFWE¼ 0.045), and bilaterally in two large, almost
symmetrical, clusters mainly comprising the parahippo-
campal and fusiform gyrus, and the hippocampus, with
some voxels extending over the thalamus (right: 32,
20, 22; T¼ 6.65; cluster level pFWE< 0.001; left
26, 34, 4; T¼ 6.41; cluster level pFWE< 0.001)
(Figure 2). The strongest negative correlation (right
temporo-parietal junction: 48, 48, 14; T¼ 7.19; peak
level pFWE¼ 0.062), fell slightly above the statistical
significance threshold chosen a priori (i.e.
pFWE¼ 0.05).
Conversely, no significant correlation was observed
between age and FDG uptake in healthy volunteers.
No significant correlations, whether positive or
negative, were observed between disease duration or
migraine days and FDG uptake. Correlations at a
more permissive statistical threshold (p< 0.001 uncor-
rected) are depicted in Figure 3 for comparison pur-
poses. The region in the posterior pons positively
correlated with age in migraine patients remained sig-
nificant after controlling for disease duration (5mm
sphere small volume correction at 4, 38, 38;
T¼ 5.79; peak level pFWE< 0.001) or migraine days
(5mm sphere small volume correction at 4, 38,
38; T¼ 7.22; peak level pFWE< 0.001) (Figure 4).
Between group comparisons
The comparison between healthy volunteers and
migraine patients revealed a cluster of significantly
reduced metabolism in migraineurs located in the
right post-central gyrus extending towards the sub-
jacent white matter, both with (34, 42, 52; T¼ 6.53;
cluster level pFWE< 0.004), and without (34, 42, 52;
T¼ 6.59; cluster level pFWE< 0.003) adding age as a
nuisance variable (Figure 5). Table 2 shows differences
between groups at a p< 0.001 uncorrected threshold for
positive and negative contrasts.
Discussion
The main finding of this cross-sectional study is that,
unlike healthy subjects, migraine patients exhibit brain
metabolic modifications in relation with the ageing pro-
cess during the ages where migraine prevalence peaks.
These modifications are localized in regions that have
been linked to the pathophysiology of the disease on
numerous occasions in the past. Furthermore, in
migraineurs, age is more robustly correlated with meta-
bolic changes than disease duration or the number of
monthly migraine days. Put altogether, results of this
study suggest that from a metabolic perspective, more
than the strain produced by intermittent headache
attacks, the physiological state of the brain of migraine
patients is modelled by the constant interaction with
the environment.
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Figure 1. Ages of the participants in each group plotted over
estimated migraine prevalence curves (left y axis corresponds to
migraine prevalence (%)) separated by sex (7,29). Mean and
standard deviations are also depicted.
Table 1. Characteristics of the participants. Migraine days
refers to the monthly days with migraine headache assessed







Age (mean SD) 36.10 11.4 34.37 14.6
Age range (min-max) 21–59 20–63
Female (%) 75.0 79.0
Migraine days (mean SD) 4.6 2.5











Figure 2. t-values (color-coded) of voxels where 18FDG uptake is postively correlated with age in 19 interictal episodic migraine
without aura patients (4, 28, 36). See color scale on the bottom right. Regions include the brainstem, and two large, almost
symmetrical, bilateral, clusters extending over the hippocampus, the parahippocampal and fusiform gyri, and some voxels belonging to
the thalamus.
Healthy volunteers
AgeAge Disease duration Migraine days
Migraine patients
Figure 3. Positive correlations (color-coded) between 18FDG uptake and the different clinical parameters in healthy volunteers and
migraine patients at a p< 0.001 uncorrected threshold.
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More than 10 years ago, the first study addressing
the correlation between FDG uptake and clinical vari-
ables in migraine patients was published. Focusing on
the imprint of the disease on the brain, age was con-
sidered a nuisance variable in the analyses (12). Results
showed a progressive glucose hypometabolism in rela-
tion to disease duration in brain regions belonging to
the central pain matrix. Positive correlations were only
found in white matter regions (frontal and parietal),
and no changes were observed in the brainstem (12).
Our contrasting results clearly challenge the consider-
ation of age as a covariate of no interest and place it in
a rather central position in the model.
The posterior pons, age, and migraine
The limited spatial resolution of PET makes a precise,
unequivocal, anatomical segregation almost impossible,
Positive correlations with 18FDG uptake in migraine
Age
(controlling for disease duration)
Age






























Figure 4. Correlations between18FDG uptake and age (controlling for disease duration (upper left) or migraine days (bottom left)),
and FDG-uptake and disease duration (controlling for age (top right)) or migraine days (controlling for age (bottom right)) at a
p< 0.001 uncorrected threshold. Voxels in the posterior pons, parahippocampal gyrus, fusiform gyrus, and thalamus where 18FDG
uptake is postively correlated with age in migraine patients still appear after controlling for the other variables.
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and especially at the brainstem level. The voxels in the
pons where FDG-uptake showed a positive correlation
with age in migraine patients in our study could involve
numerous structures like the trigeminal brainstem
nuclei, the dorsal raphe nucleus, the nucleus tractus
solitarius, the locus coeruleus and the nucleus cuneatus,
to name a few (13). Therefore, although a precise ana-
tomo-functional interpretation of our findings would
remain largely hypothetical, mechanistic assumptions
about the pathophysiology of the disease could readily
be drawn. The posterior pons has been repeatedly asso-
ciated with migraine in the past, up to the point of
being considered a migraine generator (14–16).
Activation of this region has been described during
both the premonitory and the headache phases of the
disease (17), suggesting that it might occur as a protect-
ive mechanism, aiming to refrain from an imminent
headache attack. If this is the case, the possibility
arises that age-related increases in metabolism in the
posterior pons might represent a long-term compensa-
tory effort trying to impede headache crises from occur-
ring. Such a hypothesis would serve as a justification
for the common clinical observation of migraine dis-
appearing (or reducing in severity and frequency) with
advancing age. If the metabolism (and then activity) of
the brainstem increases with age in migraine patients, it
would forcefully enhance thalamocortical activity, and
finally lead to a normalization of the otherwise
increased cortical responsivity (18). Metabolic connect-
ivity analyses coupled with electrophysiological studies
would be needed in order to verify this hypothesis.
Furthermore, if metabolic modifications in the brain-
stem of migraine patients are indeed the explanation
behind migraine waning with age, such an adaptive
change could be externally facilitated in order to con-
trol migraine symptoms. As before, this possibility
would also need to be corroborated in future
experiments.
Just as mentioned in the introduction, our study is
not the first to describe brain age-related modifications
in migraine patients. Chong et al. evaluated the differ-
ences in cortical thickness in relation with age between
migraineurs and healthy controls (10). They reported
atypical cortical thinning in association with age in
migraine, which affected the postcentral gyri bilaterally,
as well as the right fusiform gyrus and right temporal
pole. The authors concluded that migraine patients pre-
sent age-related cortical thinning that occurs regardless
of disease duration and attack frequency (10). Even if








Figure 5. Cluster of significantly reduced 18FDG uptake in the somatosensory cortex of migraine patients with respect to healthy
controls. The letter R indicates the right side of the image.
Lisicki et al. 983
Table 2. Differences in brain metabolism in patients with migraine compared with healthy controls at a p< 0.001 (uncorrected)
threshold. The region of significantly different metabolism at a pFWE< 0.05 statistical threshold is shaded in grey.
Hypometabolism in migraine
Cluster size Peak Peak Peak
x,y,z {mm} x,y,z {mm} x,y,z {mm} (Voxels) T p(FWE-corr) p(unc)
Right superior parietal lobe 34 42 52 261 6.5884 0.0031 0.0000
Left inferior frontal lobe 48 24 14 67 4.7576 0.3085 0.0000
Left middle temporal gyrus 64 54 2 90 4.6634 0.3722 0.0000
60 48 10 3.7103 0.9851 0.0003
Left precuneus 12 56 58 161 4.6215 0.4030 0.0000
16 42 58 4.1048 0.8276 0.0001
Left cuneus 8 76 18 61 4.5916 0.4259 0.0000
Left precentral gyrus 36 24 58 52 4.4875 0.5104 0.0000
Right Rolandic operculum 54 10 2 64 4.1814 0.7708 0.0001
Left superior occipital gyrus 20 78 30 56 4.1624 0.7856 0.0001
Right parahipocampal gyrus 22 24 24 30 4.1226 0.8150 0.0001
Left frontal infero-orbital gyrus 40 30 4 74 4.0980 0.8322 0.0001
Left supramarginal gyrus 62 30 32 30 4.0971 0.8329 0.0001
Left prefrontal cortex 16 42 26 25 4.0368 0.8716 0.0001
Left parahippocampus 16 26 22 29 4.0127 0.8855 0.0001
Left angular gyrus 56 44 40 14 3.9992 0.8929 0.0001
Right prefrontal cortex 54 10 48 29 3.9495 0.9177 0.0002
Left parietal white matter 16 54 32 13 3.8687 0.9495 0.0002
Left superior parietal gyrus 34 50 46 26 3.8507 0.9552 0.0002
Left pre-motor cortex 52 2 36 26 3.7889 0.9714 0.0003
Right frontal infero-orbital gyrus 42 34 0 24 3.7559 0.9780 0.0003
Left frontal white matter 32 12 48 18 3.7546 0.9782 0.0003
Left prefrontal cortex 32 34 30 8 3.7333 0.9818 0.0003
Left extra-striate visual cortex 36 72 12 15 3.7329 0.9818 0.0003
Left extra-striate visual cortex 46 80 0 15 3.6834 0.9884 0.0004
Right middle temporal gyrus 64 6 24 4 3.6652 0.9902 0.0004
Right supramarginal gyrus 64 26 30 3 3.6223 0.9937 0.0004
Left superior parietal lobe 28 66 50 15 3.6012 0.9950 0.0005
Right superior parietal lobe 24 52 64 17 3.5886 0.9956 0.0005
Left fusiform gyrus 56 42 12 6 3.5533 0.9971 0.0005
Left fusiform gyrus 42 46 24 5 3.5471 0.9973 0.0005
Right frontal white matter 16 4 58 4 3.5364 0.9976 0.0006
Right pre-motor cortex 56 2 36 3 3.5146 0.9982 0.0006
Left superior parietal lobe 22 74 42 4 3.4428 0.9993 0.0007
Right pre-frontal cortex 16 34 38 4 3.4154 0.9996 0.0008
Left dorsal posterior cingulate 6 42 42 2 3.4090 0.9996 0.0008
Left supramarginal gyrus 58 20 36 3 3.4086 0.9996 0.0008
Left middle temporal gyrus 56 42 6 1 3.3640 0.9998 0.0009
Hypermetabolism in migraine
Cluster Peak Peak Peak
x,y,z {mm} x,y,z {mm} x,y,z {mm} Equivk T p(FWE-corr) p(unc)
Right angularþ supramarginal gyri 34 50 34 53 4.4652 0.5294 0.0000
Right middle frontal gyrus 38 4 38 36 3.8750 0.9474 0.0002
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brainstem, a region that evidently cannot be compared
with the study by Chong et al. analysing the cerebral
cortex, the correlated regions that we found at the cor-
tical level do not strictly overlap with the ones they
described. One possible explanation for the contrasting
results between our study and the one by Chong et al.
would be that cortical thinning in migraine patients is
not paired with noticeable metabolic modifications.
Studies simultaneously addressing both variables are
warranted. Of note, the strongest negative correlation
we observed in the cortex, located at the right temporo-
parietal junction (a key region of sensory processing
likely involved in migraine (14,18–22), did not reach
statistical significance after correcting for multiple
comparisons.
Differences with normal ageing
In healthy subjects, the normal process of ageing
induces a progressive hypometabolism in several brain
areas. These areas include the anterior cingulate, orbi-
tofrontal, dorsolateral and medial prefrontal cortices in
the frontal lobe, the supramarginal, superior and infer-
ior parietal cortices in the parietal lobe, the lateral tem-
poral cortex and temporal poles in the temporal lobe,
and the insula. Least affected regions during the ageing
process are the primary motor and occipital cortices,
precuneus, and notably the mesial temporal lobes and
thalamus (23,24). The distribution of this hypometabo-
lism in normal aging inversely follows the development
line of the human brain (i.e. structures that first devel-
oped are spared from an age-related metabolic deterior-
ation whereas the frontal regions, which become
metabolically active during later stages of the central
nervous system development, are the most consistently
affected by aging) (25,26). In this study no significant
metabolic modifications in relation to age were observed
in the healthy subjects group. This is likely due to the
younger range of age of our control sample (21–59
years) with respect to cohorts in most studies addressing
this phenomenon (i.e. 20–70 years). However, and per-
haps more surprising, is that in migraine patients metab-
olism in the mesial temporal lobe and thalamus was not
only maintained but rather progressively increased.
Preservation of metabolism in these structures is consist-
ent with the functional importance of thalamo-limbic
circuits in sensory integration, arousal, emotion, and
memory (25,26), and it is likely that these same under-
pinnings push it forth in migraine.
Between-groups comparison
In our study, the strongest difference observed when
comparing migraine patients and healthy volunteers,
both with or without controlling for the effect of age,
was a region of reduced FDG uptake in migraineurs
situated in the right post-central gyrus. Several 18FDG
PET studies have compared migraine patients and
healthy controls in the past (12,27,28). In one study
with a smaller sample size compared to the present
work, an increased metabolism in the posterior white
matter of migraine patients was reported. The minimal
extent threshold of 500 voxels that the authors
employed could have discarded any possible clusters
situated at the brainstem level (27). A couple of years
later, in a larger study, Kim et al. found a significant
hypometabolism in the primary somatosensory cortex
similar to the one we report in the present study. They
also described a reduced metabolism in other regions
belonging to the pain matrix (i.e. the insula, cingulate
cortex, and prefrontal cortex). Except for the anterior
cingulate cortex, results from our exploratory analyses
performed at a more permissive threshold (p< 0.001
uncorrected) exhibit some degree of overlapping with
their results (see Table 2). Finally, in one study includ-
ing chronic migraine patients, Aurora et al. have
described a relatively increased metabolism in the
pons of migraineurs (28).
Limitations
The major limitation of our study is that PET spatial
resolution is limited, and thus a precise, unambiguous
identification of small regions cannot be achieved
through this method. Also, age and disease duration
are correlated in our sample of patients (r¼ 0.698;
p< 0.01), and thus the particular effect of each cannot
be entirely separated. Furthermore, a positive control
(e.g. chronic pain) is missing in this study and because
of that the findings herein reported cannot be proven to
be migraine specific. The relatively small number of
subjects in each group could also be considered a limi-
tation of the present study. In addition, although not
considered in the original study design, on the basis of
our findings it seems plausible that performing tests to
evaluate cognitive and other cerebral functions may
have ameliorated our comprehension of the outcomes.
Finally, recall bias could certainly reduce precision
when estimating disease duration. Therefore, although
encouraging, our results would need to be corroborated
in a longitudinal study specifically addressing the cere-
bral metabolic modifications throughout the life span in
migraine patients.
Conclusions
Migraine patients exhibit metabolic modifications
in the brain in relation with ageing. As such, age
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is correlated with metabolic changes in key regions of
the brain associated with migraine’s pathophysiology
to a better extent than disease duration or the
number of migraine days. More than the repeated
headache attacks, an adaptive response to constant
exposure to environmental stimuli seemingly models
the brain of migraine sufferers.
Key findings
. Episodic migraine patients exhibit specific metabolic brain modifications while ageing.
. Age is correlated with metabolic changes in key regions of the brain previously associated with migraine’s
pathophysiology to a better extent than disease duration or the number of monthly migraine days.
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